• Researcher Profile

    Francisco Marty, MD

    Francisco Marty, MD

    Top Doctor

    Associate Professor of Medicine, Harvard Medical School


    Hematologic Oncology

    Office phone: 617-632-6064
    Fax: 617-732-6829

    Preferred contact method: office phone

    View Physician Profile


    Transplant and oncology infectious diseases, Novel diagnostics and treatments for invasive fungal disease, Cytomegalovirus, Respiratory viruses

    Dana-Farber Cancer Institute
    450 Brookline Avenue
    Yawkey 8th floor
    Boston, MA 02215

    Recent Awards

    • Best Abstracts Award (Clinical Research), American Society for Blood and Marrow Transplantation & Center for International Blood and Marrow Transplant Research, 2012 Tandem Meetings, San Diego, CA., 2012
    • Faculty Mentor Award, Brigham & Women’s Hospital, Department of Medicine., 2010
    • Faculty Teaching Award, Infectious Diseases Fellows, Brigham and Women's Hospital & Massachusetts General Hospital, 2010

    Select Publications

    • Marty FM, Lee SJ, Fahey MM, Alyea EP, Soiffer RJ, Antin JH, Baden LR. Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study. Blood. 2003;102(8):2768-76.
    • Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med. 2004;350(9):950-2.
    • Marty FM, Lowry CM, Rodriguez M, Milner DA, Pieciak WS, Sinha A, Fleckenstein L, Baden LR. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. Clin Infect Dis. 2005;41(1):e5-8.
    • Rodriguez M, Chou S, Fisher DC, Girolami UD, Amato AA, Marty FM. Lyme Meningoradiculitis and Myositis after Allogeneic Hematopoietic Stem Cell Transplantation. Clin Infect Dis. 2005;41(12):e112-4.
    • Marty FM, Lowry CM, Cutler CS, Campbell BJ, Fiumara K, Baden LR, Antin JH. Voriconazole and Sirolimus Coadministration after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2006;12(5):552-9.
    • Martin SI, Marty FM, Fiumara K, Treon SP, Gribben JG, Baden LR. Infectious complications associated with alemtuzumab use for lymphoproliferative disorders. Clin Infect Dis. 2006;43(1):16-24.  
    • Marty FM, Koo S, Bryar J, Baden LR. (1→3)-beta-D-glucan assay positivity in patients with Pneumocystis (carinii) jiroveci pneumonia. Ann Intern Med. 2007;147(1):70-2.
    • Seeley WW, Marty FM*, Holmes TM, Upchurch K, Soiffer RJ, Antin JH, Baden LR, Bromfield EB. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology. 2007;69(2):156-65. (*co-first authorship)
    • Marty FM, Bryar J, Browne SK, Schwarzberg T, Ho VT, Bassett IV, Koreth J, Alyea EP, Soiffer RJ, Cutler CS, Antin JH, Baden LR. Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis. Blood. 2007;110(2):490-500.
    • Krause PJ, Gewurz BE, Hill D, Marty FM, Vannier E, Foppa IM, Furman RR, Neuhaus E, Skowron G, Gupta S, McCalla C, Pesanti EL, Young M, Heiman D, Hsue G, Gelfand JA, Wormser GP, Dickason J, Bia FJ, Hartman B, Telford SR, Christianson D, Dardick K, Coleman M, Girotto JE, Spielman A. Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis. 2008;46(3):370-6.
    • Hammond SP, Borchelt AM, Ukomadu C, Ho VT, Baden LR, Marty FM. Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2009;15(9):1049-59.
    • Kallenberg MH, Gill RR, Factor RE, Bryar JM, Rubin RH, Jacobson FL, Marty FM. Diagnostic Efficacy and Safety of Computed Tomography-guided Transthoracic Needle Biopsy in Patients with Hematologic Malignancies. Acad Radiol. 2009;16(11):1408-15.
    • Koo S, Bryar JM, Page JH, Baden LR, Marty FM. Diagnostic Performance of the (1→3)-b-D-Glucan Assay for Invasive Fungal Disease. Clin Infect Dis. 2009;49(11):1650-9. 
    • Koo S, Bryar JM, Baden LR, Marty FM. Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis. J Clin Microbiol. 2010;48(4):1255-60. 
    • Kubiak DW, Bryar JM, McDonnell AM, Delgado-Flores JO, Mui E, Baden, LR, Marty FM. Evaluation of Caspofungin or Micafungin as Empiric Antifungal Therapy in Adult Patients with Persistent Febrile Neutropenia: A Retrospective, Sequential Cohort Analysis. Clin Ther. 2010;32(4):637-648.
    • Hammond SP, Marty FM, Bryar JM, DeAngelo DJ, Baden LR. Invasive fungal disease in patients treated for newly diagnosed acute leukemia. Am J Hematol. 2010; 85(9):695-9.
    • Avery RK, Marty FM, Strasfeld L, Lee I, Arrieta A, Chou S, Tatarowicz W, Villano S. Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients. Transpl Infect Dis. 2010; 12(6):489-96.
    • Marty FM, Petschnigg EM, Hammond SP, Ready JE, Ho VT, Soiffer RJ, Magee C, Milner DA, Antin JH, Baden LR. Invasive Fungal Disease following Remote Inoculation in Transplantation Recipients. Clin Infect Dis. 2011; 52(1):e7-10.
    • Issa NC, Marty FM, Gagne LS, Koo S, Verrill KA, Alyea EP, Cutler CS, Koreth J, Armand P, Ho VT, Antin JH, Soiffer RJ, Baden LR. Seroprotective Titers against 2009-H1N1 Influenza A Virus after Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Recipients. Biol Blood Marrow Transplant. 2011; 17(3):434-8.
    • Marty FM, Ljungman P, Papanicolaou GA, Winston DJ, Chemaly RF, Strasfeld L, Young JH, Rodriguez T, Maertens J, Schmitt M, Einsele H, Ferrant A, Lipton JH, Villano SA, Chen H, Boeckh M, Maribavir 1263-300 Clinical Study Group. Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplantation: a phase 3, double-blind, placebo-controlled, randomised trial. Lancet Infect Dis. 2011;11(4):284-92.
    • Herrera AF, Soriano G, Belizzi AM, Hornick JL, Ho VT, Ballen KK, Baden LR, Cutler CS, Antin JH, Soiffer RJ, Marty FM. Cord Colitis Syndrome in Cord-Blood Stem-Cell Transplantation. N Engl J Med. 2011;365(9):315-24.
    • Chen YB, Driscoll JP, McAfee SL, Spitzer TR, Rosenberg ES, Sanders R, Moss RB, Fang F, Marty FM. Treatment of Parainfluenza 3 Infection with DAS181 in a Patient After Allogeneic Stem Cell Transplantation. Clin Infect Dis. 2011;53(7):e77-e80.
    • Cornely OA, Marty FM, Stucker F, Pappas PG, Ullmann AJ. Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease. Mycoses 2011; 54(6):e838-47.
    • Hammond SP, Baden LR, Marty FM. Mortality in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients with Mucormycosis 2001-2009. Antimicrob Agents Chemother. 2011;55(11):5018-21.
    • Issa NC, Koo S, Lynch RC, Gay C, Hammond SP, Baden LR, Ghobrial IM, Finkelman MA, Marty FM. Serum Galactomannan and (1→3) β-D-Glucan Assays in Patients with Multiple Myeloma and Waldenstrom’s Macroglobulinemia. J Clin Microbiol. 2012;50(3):1054-6.
    • Kubiak DW, Koo S, Hammond SP, Armand P, Baden LR, Antin JH, Marty FM. Safety of Posaconazole and Sirolimus Co-administration in Allogeneic Hematopoietic Stem-Cell Transplantation. Biol Blood Marrow Transplant. 2012;18(9):1462-5.
    • Hammond SP, Gagne LS, Stock SR, Marty FM, Gelman RS, Marasco WA, Poritz MA, Baden LR. Respiratory Virus Detection in Immunocompromised Patients with FilmArray Respiratory Panel Compared to Conventional Methods. J Clin Microbiol. 2012;50(10):3216-21.
    • Hill JA, Koo S, Guzman Suarez BB, Ho VT, Cutler C, Koreth J, Armand P, Alyea EP, Baden LR, Antin JH, Soiffer RJ, Marty FM. Cord-blood hematopoietic stem-cell transplantation confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis. Biol Blood Marrow Transplant. 2012;18(11):1638-48.
View Physician Directory

Find a Clinical Trial

Support Cancer

Give Now